LAUSR

Gamma‐aminobutyric acid (GABA) abnormalities have been implicated in a range of neuropsychiatric disorders. Despite substantial interest in probing GABA in vivo, human imaging studies relying on magnetic resonance spectroscopy (MRS) have generally been hindered by technical challenges, including GABA’s relatively low concentration and spectral overlap with other metabolites. Although past studies have shown moderate‐to‐strong test‐retest repeatability and reliability of GABA within certain brain regions, many of these studies have been limited by small sample sizes.